EZH2 Inhibition Boosts Tumor Immunogenicity and TIL Reactivity in Lung Cancer
Daniel R. Plaugher, Christian M. Gosser, Yindan Lin…·Christine F. Brainson
This study shows that inhibiting EZH2 in lung cancer enhances immunogenicity and TIL reactivity by altering the tumor microenvironment and T cell properties.